Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

International Cannabis Solutions – Reaction to Ontario's Plans for Legalized Cannabis
  • USA - English


News provided by

ICS

Sep 15, 2017, 08:15 ET

Share this article

Share toX

Share this article

Share toX


Toronto, ON (PRWEB) September 15, 2017 -- International Cannabis Solutions, based out of Toronto, Ontario, Canada; has a global reach with an expert team with over 150 years of cumulative experience in healthcare, education, pain management, addiction medicine, pharmacology, and more specifically, Cannabis and Cannabinoid knowledge. We are uniquely positioned to address the Federal Government’s Cannabis Task Force recommendations and needs analysis findings to provide evidenced based knowledge and consultancy for all levels of government within Canada and globally.

We believe the cannabis industry as a whole has a responsibility to help our legislators in every way possible to arrive an encompassing evidenced based approach, maintaining public safety to achieve the Ontario Government’s ambitions for both medical and responsible well- educated adult use markets

Post this

Following the Ontario provincial government's announcement of a framework for legal cannabis sales and use, International Cannabis Solutions Incorporated would like to offer the following statements:

We applaud the Ontario governments recognition of the time sensitive nature of this initiative and their commitment to meet the Canadian Federal Governments time line for legalization of Cannabis in Canada July, 1st, 2018

Keeping the age at which an individual can legally obtain cannabis at 19 (i.e. in line with alcohol purchase) is a prudent move. First, it reduces the risk of co-ingestion also it creates a preventive framework for youth. Protecting the developing brains of our next generation (our youth) is imperative.

We are encouraged by the Ontario government’s commitment to education, as it is necessary not only to mitigate risk, but also to educate the general public on the features, benefits and responsible use associated with cannabis to make informed decisions. Educational programming should ‘evidenced based’ where possible at all times.

We encourage a further look to successful international development in the industry as part of “The Ontario Government” ongoing process, ie. Portugal, The Netherlands.

“We believe the cannabis industry as a whole has a responsibility to help our legislators in every way possible to arrive an encompassing evidenced based approach, maintaining public safety to achieve the Ontario Government’s ambitions for both medical and responsible well- educated adult use markets. We are encouraged that there will be further stakeholder consultations before the final bill is tabled in the fall of 2017 and ICS would be willing participants in these consultations. We look forward to hearing further details regarding the development of distribution channels and we are excited to contribute in any way we can to provide all levels of government our expertise,”. said Kevin Hall, President and CEO of International Cannabis Solutions.

Dr. Peter M Blecher, (Medical Director, CPM Centre for Pain Management, Oshawa; Global VP & Medical Director, ICS; Chief Medical Officer, Starseed Medicinal, Inc) had this to say : "As both an ER doctor and chronic pain physician who has been practicing in the province of Ontario for well over 20 years, I have been first-hand witness to the ravages and devastation that opioids have had in our society. The growing adoption and judicious use of opioid-sparing cannabinoids, has frankly transformed my pain practice, and that of many of my colleagues. While no one thing will ever be a ‘panacea’ for eliminating suffering, the use of cannabinoids is having in immense positive impact on thousands of patients, in more safely managing their pain symptoms, and co-morbidities of anxiety and poor sleep hygiene, to mention just a few.

I am delighted to be associated with ICS, in helping them to further my own commitment to bring evidence-based education about medical cannabis to not only my colleagues and patients, but to the broader stakeholders such as trade unions, insurers, and government agencies – all of whom should have strong vested interests in this seeing this exciting frontier of medicine being managed properly and ethically, while remaining sympathetic to the countless patients relying on this plant’s still-emerging and extraordinary medical potential.”

Furthermore, ICS Canada has collaborative enterprises with a variety of important stakeholders, from which consultation and resources are shared in order to move the field forward. With Ontario Government pro-action as indicated by their announcements today, particular stakeholder groups such as Licenced Producers will also be impacted by these decisions.

"We are delighted to have clarity on the intended distribution model for the province of Ontario. We can now align the distribution aspects of our business more specifically to this plan and project the costs associated with product delivery with more certainty. We are excited to start doing business in Ontario. Furthermore, we are encouraged by the decision to engage with industry stakeholders with a focus on health and safety. For IFP, achieving the highest possible standards for cannabis production is a primary guiding objective.," added Paul Grenier, Lead Business Strategist – Intrinsic Farmed Products – Late Stage ACMPR Applicant

Kevin Hall and other ICS stakeholders are available to media for interviews.

Kevin Hall, ICS, http://www.internationalcannabissolutions.net, +1 416-482-2662, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.